ZimVie (NASDAQ:ZIMV) Sees Strong Trading Volume - Time to Buy?

ZimVie Inc. (NASDAQ:ZIMV - Get Free Report) shares saw an uptick in trading volume on Tuesday . 415,192 shares changed hands during trading, an increase of 87% from the previous session's volume of 221,832 shares.The stock last traded at $18.74 and had previously closed at $18.76.

Analyst Ratings Changes

A number of brokerages have recently issued reports on ZIMV. Barclays raised ZimVie from an "underweight" rating to an "equal weight" rating and increased their target price for the stock from $9.00 to $19.00 in a research note on Tuesday. Needham & Company LLC reissued a "hold" rating on shares of ZimVie in a report on Wednesday, April 9th. UBS Group lowered their price target on shares of ZimVie from $16.00 to $10.00 and set a "neutral" rating on the stock in a research note on Thursday, May 15th. Wall Street Zen cut shares of ZimVie from a "strong-buy" rating to a "buy" rating in a research note on Friday, July 18th. Finally, B. Riley began coverage on shares of ZimVie in a report on Thursday, April 10th. They set a "buy" rating and a $16.00 price objective on the stock. Three analysts have rated the stock with a hold rating, one has given a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $17.00.

ZimVie Price Performance

The company's fifty day moving average is $10.04 and its two-hundred day moving average is $11.10. The company has a debt-to-equity ratio of 0.58, a quick ratio of 1.48 and a current ratio of 2.14. The firm has a market cap of $521.35 million, a price-to-earnings ratio of 23.71 and a beta of 2.07.

ZimVie (NASDAQ:ZIMV - Get Free Report) last issued its quarterly earnings data on Thursday, May 8th. The company reported $0.27 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.21 by $0.06. The company had revenue of $112.00 million during the quarter, compared to the consensus estimate of $113.10 million. ZimVie had a negative net margin of 4.40% and a positive return on equity of 5.53%. Equities research analysts forecast that ZimVie Inc. will post 0.6 EPS for the current year.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of the company. J. Goldman & Co LP grew its stake in ZimVie by 167.5% during the 4th quarter. J. Goldman & Co LP now owns 1,425,810 shares of the company's stock worth $19,890,000 after buying an additional 892,785 shares during the last quarter. Ancora Advisors LLC boosted its holdings in shares of ZimVie by 140.1% during the first quarter. Ancora Advisors LLC now owns 269,290 shares of the company's stock valued at $2,908,000 after acquiring an additional 157,130 shares during the period. American Century Companies Inc. grew its position in shares of ZimVie by 23.9% during the fourth quarter. American Century Companies Inc. now owns 628,050 shares of the company's stock worth $8,761,000 after acquiring an additional 121,053 shares during the last quarter. Gamco Investors INC. ET AL grew its position in shares of ZimVie by 22.6% during the first quarter. Gamco Investors INC. ET AL now owns 636,341 shares of the company's stock worth $6,872,000 after acquiring an additional 117,229 shares during the last quarter. Finally, Dimensional Fund Advisors LP increased its holdings in shares of ZimVie by 9.4% in the 4th quarter. Dimensional Fund Advisors LP now owns 1,244,938 shares of the company's stock worth $17,367,000 after acquiring an additional 107,461 shares during the period. Institutional investors own 95.63% of the company's stock.

About ZimVie

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.